ID: ALA4798414

Max Phase: Preclinical

Molecular Formula: C17H15BrFN3O2S

Molecular Weight: 343.38

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Br.N=C(N)SCc1ccc(CN2C(=O)C(=O)c3cc(F)ccc32)cc1

Standard InChI:  InChI=1S/C17H14FN3O2S.BrH/c18-12-5-6-14-13(7-12)15(22)16(23)21(14)8-10-1-3-11(4-2-10)9-24-17(19)20;/h1-7H,8-9H2,(H3,19,20);1H

Standard InChI Key:  CUDOVIRTPQEIRT-UHFFFAOYSA-N

Associated Targets(Human)

ALDH1A1 Tchem Aldehyde dehydrogenase 1A1 (77053 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALDH2 Tclin Aldehyde dehydrogenase (509 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALDH3A1 Tchem Aldehyde dehydrogenase dimeric NADP-preferring (307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 343.38Molecular Weight (Monoisotopic): 343.0791AlogP: 2.68#Rotatable Bonds: 4
Polar Surface Area: 87.25Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.54CX LogP: 2.74CX LogD: 0.40
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.51Np Likeness Score: -1.23

References

1. Dinavahi,SS.; Gowda,R.; Bazewicz,CG.; Battu,MB.; Lin,JM.; Chitren,RJ.; Pandey,MK.; Amin,S.; Robertson,GP.; Gowda,K..  (2020)  Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents.,  187  [PMID:31887569] [10.1016/j.ejmech.2019.111962]

Source